United States · FDA National Drug Code directory

mFLUSIVA

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 80777-500_3dd1c6d2-b054-4803-bb21-460b1b090d4c
Product NDC: 80777-500
Form: INJECTION, SUSPENSION
Composition / generic term: Influenza Vaccine, mRNA
Labeler: Moderna US, Inc.
Marketing category: BLA
Marketing start / end (source format): 20260805
Source listing expiry: 20271231

Source-listed ingredients

RNA-101-BFL3 — 12.5 ug/.38mL
RNA-101-BFL6 — 12.5 ug/.38mL
RNA-101-BFL5 — 12.5 ug/.38mL

These values do not establish equivalence or a dose recommendation.

Packages

10 SYRINGE, PLASTIC in 1 CARTON (80777-500-20) / .38 mL in 1 SYRINGE, PLASTIC (80777-500-18) · 80777-500-20

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →